Colossal's Artificial Egg Is a Great Demo, Not De-Extinction

Colossal Biosciences says it solved the chicken-or-the-egg riddle. What they actually built is a better Tupperware for bird embryos, backed by $620 million and a very good marketing department.

Watching a chick hatch is an ancient, messy miracle. Seeing one do it inside a clear, 3D-printed cup is something else entirely. That’s the vision from Colossal Biosciences, the company that wants to bring back the woolly mammoth. They’re claiming a “fully artificial egg,” a solution to the oldest riddle. The Hollywood-produced videos are slick. But the video is not the story. The truth, as usual, is less about fundamental breakthroughs and more about clever engineering. Colossal built a better incubator. It’s an impressive piece of hardware, but it’s still just a container.

The device itself is a 3D-printed lattice shaped like an oval, which holds the contents poured from a real chicken egg. The key innovation is a proprietary silicone-based membrane coating the inside. This skin is permeable to oxygen, mimicking the gas exchange of a real shell and solving a major failure point of prior attempts. Teams in Japan have been hatching birds in artificial containers since 1998, but those systems often required supplemental oxygen and had lower success rates. Colossal’s membrane may be a genuine improvement, but it’s just one piece of the puzzle. They still have to manually add calcium carbonate to the yolk mixture because the plastic shell, unlike a real one, can’t be leached for minerals by the growing embryo. It's a workaround, not a recreation of nature.

Colossal has raised over $620 million not by selling lab equipment, but by selling a story of resurrection. This artificial egg is the latest chapter. It’s not meant to disrupt the poultry industry; it’s meant to generate headlines and assure investors that the moonshot projects—the dodo, the giant moa, the mammoth—are on a tangible path. By claiming an 'impossible' victory, even one that antagonizes the small group of scientists doing this work for decades, Colossal keeps the capital flowing. In this game, the demo is the product. The company wins by maintaining narrative momentum, while the quiet, foundational work of academic research gets drowned out by a slick press tour.

In the next few years, this technology will not bring back the dodo. The bottleneck was never the egg. It's the monumental task of successfully editing thousands of genes into a host genome, a feat that is orders of magnitude more complex than building a better box. The more immediate application for these artificial shells will likely be in conservation, giving researchers an unprecedented window into the development of at-risk bird species. But the de-extinction target is what secures the funding. The real question this work surfaces has nothing to do with whether we can rebuild extinct fauna. It’s about what we are becoming comfortable growing in a lab for any purpose at all. Who decides which life gets a plastic womb?